Physician profile
Molly Steele
NPI 1598292260
$2,424.50
in general payments reported to CMS, 2019-2025
20 companies · $668 in 2025
The $668 reported for 2025 was more than what 97% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $241 · 2023: $429 · 2024: $765 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $360.61 | 2021-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $290.40 | 2023-2025 | Zurzuvae |
| Pfizer INC. | $246.60 | 2021-2025 | |
| Shield Therapeutics INC | $219.81 | 2024 | |
| Abbvie INC. | $174.82 | 2021-2025 | |
| Novo Nordisk INC | $160.57 | 2021-2024 | Wegovy |
| Organon LLC | $138.60 | 2021-2025 | Nexplanon |
| Biogen, INC. | $119.33 | 2025 | Zurzuvae |
| Axonics, INC. | $114.04 | 2023-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $108.69 | 2021-2024 | |
| Hologic Sales and Service, LLC | $102.77 | 2021-2024 | Thinprep 2000 Processor, Aptima, Novasure |
| Boston Scientific Corporation | $90.89 | 2025 | Axonics |
| Sumitomo Pharma America, INC. | $65.41 | 2024-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $52.63 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $50.57 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $41.38 | 2021-2022 | |
| Exeltis, USA INC. | $24.37 | 2021-2023 | Nuvessa |
| Ethicon US, LLC | $23.44 | 2021 | |
| Supernus Pharmaceuticals, INC. | $22.94 | 2025 | Qelbree |
| Therapeuticsmd, INC. | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.